Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $5.1 million.

  • Fortress Biotech's Accumulated Depreciation & Amortization fell 5777.68% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 5777.68%. This contributed to the annual value of $12.1 million for FY2024, which is 3616.73% up from last year.
  • As of Q3 2025, Fortress Biotech's Accumulated Depreciation & Amortization stood at $5.1 million, which was down 5777.68% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Accumulated Depreciation & Amortization registered a high of $13.3 million during Q1 2023, and its lowest value of $4.9 million during Q1 2025.
  • In the last 5 years, Fortress Biotech's Accumulated Depreciation & Amortization had a median value of $9.3 million in 2024 and averaged $9.3 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 4699.78% in 2021, then tumbled by 5805.28% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's Accumulated Depreciation & Amortization stood at $9.4 million in 2021, then surged by 32.49% to $12.4 million in 2022, then fell by 28.56% to $8.9 million in 2023, then soared by 36.17% to $12.1 million in 2024, then plummeted by 58.28% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $5.0 million for Q2 2025, and $4.9 million during Q1 2025.